Person:
SALMAN, ANDAÇ

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

SALMAN

First Name

ANDAÇ

Name

Filters

2020 - 20213
Reset filters

Settings

Start date: 2020 × Subject: COVID-19 ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends
    (WILEY, 2021-03) SALMAN, ANDAÇ; Esen-Salman, Kubra; Akin-cakici, Ozlem; Kardes, Sinan; Salman, Andac
    Coronavirus disease 2019 (COVID-19) pandemic had substantial effect both on daily life and medical practice. Internet data have been used to analyze the trends in public interest in various medical conditions and treatments. The aim of this study is to analyze the public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic. Google Trends was queried for a total of 120 dermatological search queries. Three periods of 2020 ([March 15-May 9], [May 10-July 4], and [July 5-October 31]) were compared with the previous 4 years (2016-2019). A significantly decreased interest in skin cancers and certain dermatologic conditions (eg, pityriasis rosea and scabies) was observed throughout the study period. Whereas a significant increase of interest in dry skin, hair shedding, oily hair, atopic dermatitis, and hand eczema was detected during the study. An initial decrease in interest was followed by a significant increase for acne, comedones, melasma, rosacea, botox, dermaroller, and peeling. The study demonstrated a significant impact of the COVID-19 pandemic on the public interest in dermatology. The present results would help to create healthcare policies and information sources, which can meet the public demand. The reasons for the observed trends and their effect on patient outcomes might be of interest for future studies.
  • Thumbnail Image
    PublicationOpen Access
    Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology
    (DERI ZUHREVI HASTALIKLAR DERNEGI, 2020-06-29) SALMAN, ANDAÇ; Salman, Andac; Alper, Sibel; Atakan, Nilgun; Baskan, Emel Bulbul; Borlu, Murat; Canpolat, Filiz; Erdem, Teoman; Erdem, Yasemin; Gul, Ulker; Kartal, Selda Pelin; Koca, Rafet; Kucuk, Ozlem Su; Ogretmen, Zerrin; Ozkaya, Esen; Saricaoglu, Hayriye; Savk, Ekin; Taskapan, Oktay; Utas, Serap; Kocaturk, Emek
  • Thumbnail Image
    PublicationOpen Access
    The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
    (WILEY, 2021-03) SALMAN, ANDAÇ; Kocaturk, Emek; Salman, Andac; Cherrez-Ojeda, Ivan; Criado, Paulo Ricardo; Peter, Jonny; Comert-Ozer, Elif; Abuzakouk, Mohamed; Agondi, Rosana Camara; Al-Ahmad, Mona; Altrichter, Sabine; Arnaout, Rand; Arruda, Luisa Karla; Asero, Riccardo; Bauer, Andrea; Ben-Shoshan, Moshe; Bernstein, Jonathan A.; Bizjak, Mojca; Boccon-Gibod, Isabelle; Bonnekoh, Hanna; Bouillet, Laurence; Brzoza, Zenon; Busse, Paula; Campos, Regis A.; Carne, Emily; Conlon, Niall; Criado, Roberta F.; de Souza Lima, Eduardo M.; Demir, Semra; Dissemond, Joachim; Gunaydin, Sibel Dogan; Dorofeeva, Irina; Ensina, Luis Felipe; Ertas, Ragip; Ferrucci, Silvia Mariel; Figueras-Nart, Ignasi; Fomina, Daria; Franken, Sylvie M.; Fukunaga, Atsushi; Gimenez-Arnau, Ana M.; Godse, Kiran; Goncalo, Margarida; Gotua, Maia; Grattan, Clive; Guillet, Carole; Inomata, Naoko; Jakob, Thilo; Karakaya, Gul; Kasperska-Zajac, Alicja; Katelaris, Constance H.; Kosnik, Mitja; Krasowska, Dorota; Kulthanan, Kanokvalai; Kumaran, M. Sendhil; Lang, Claudia; Ignacio Larco-Sousa, Jose; Lazaridou, Elisavet; Leslie, Tabi Anika; Lippert, Undine; Llosa, Oscar Calderon; Makris, Michael; Marsland, Alexander; Medina, Iris, V; Meshkova, Raisa; Palitot, Esther Bastos; Parisi, Claudio A. S.; Pickert, Julia; Ramon, German D.; Rodriguez-Gonzalez, Monica; Rosario, Nelson; Rudenko, Michael; Rutkowski, Krzysztof; Sanchez, Jorge; Schliemann, Sibylle; Sekerel, Bulent Enis; Serpa, Faradiba S.; Serra-Baldrich, Esther; Song, Zhiqiang; Soria, Angele; Staevska, Maria; Staubach, Petra; Tagka, Anna; Takahagi, Shunsuke; Thomsen, Simon Francis; Treudler, Regina; Vadasz, Zahava; Rodrigues Valle, Solange Oliveira; Van Doorn, Martijn B. A.; Vestergaard, Christian; Wagner, Nicola; Wang, Dahu; Wang, Liangchun; Wedi, Bettina; Xepapadaki, Paraskevi; Yucel, Esra; Zalewska-Janowska, Anna; Zhao, Zuotao; Zuberbier, Torsten; Maurer, Marcus
    Introduction The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown. Aim To understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19. Materials and Methods Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed the impact of the pandemic on patient consultations, remote treatment, changes in medications, and clinical consequences. Results The COVID-19 pandemic severely impairs CU patient care, with less than 50% of the weekly numbers of patients treated as compared to before the pandemic. Reduced patient referrals and clinic hours were the major reasons. Almost half of responding UCARE physicians were involved in COVID-19 patient care, which negatively impacted on the care of urticaria patients. The rate of face-to-face consultations decreased by 62%, from 90% to less than half, whereas the rate of remote consultations increased by more than 600%, from one in 10 to more than two thirds. Cyclosporine and systemic corticosteroids, but not antihistamines or omalizumab, are used less during the pandemic. CU does not affect the course of COVID-19, but COVID-19 results in CU exacerbation in one of three patients, with higher rates in patients with severe COVID-19. Conclusions The COVID-19 pandemic brings major changes and challenges for CU patients and their physicians. The long-term consequences of these changes, especially the increased use of remote consultations, require careful evaluation.